EGFR and head and neck squamous cell carcinoma: Another bifunctional antibody targeting EGFR and transforming growth factor-beta (TGF-B) called BCA101 showed a clear signal of efficacy in treatment naïve HNSCC when given in combination with Pembrolizumab [19].